These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 8362515)

  • 1. Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn.
    Dooren MC; van Kamp IL; Kanhai HH; Gravenhorst JB; von dem Borne AE; Engelfriet CP
    Vox Sang; 1993; 65(1):55-8. PubMed ID: 8362515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR).
    Dooren MC; Kuijpers RW; Joekes EC; Huiskes E; Goldschmeding R; Overbeeke MA; von dem Borne AE; Engelfriet CP; Ouwehand WH
    Lancet; 1992 May; 339(8801):1067-70. PubMed ID: 1349101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of maternal HLA A, B and C antibodies associated with a mild course of haemolytic disease of the newborn. Group for the Study of Protective Maternal HLA Antibodies in the Clinical Course of HDN.
    Neppert J; v Witzleben-Schürholz E; Zupanska B; Bartz L; Greve O; Eichler H; Kerowgan M; Wichmann MG
    Eur J Haematol; 1999 Aug; 63(2):120-5. PubMed ID: 10480291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Rh antibodies in haemolytic disease of the newborn.
    Hadley AG; Kumpel BM
    Baillieres Clin Haematol; 1993 Jun; 6(2):423-44. PubMed ID: 8043933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the monocyte chemiluminescent response to anti-D-sensitized red cells by Fc gamma RI-blocking antibodies which ameliorate the severity of haemolytic disease of the newborn.
    Shepard SL; Noble AL; Filbey D; Hadley AG
    Vox Sang; 1996; 70(3):157-63. PubMed ID: 8740008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild course of fetal RhD haemolytic disease due to maternal alloimmunisation to paternal HLA class I and II antigens.
    Eichler H; Zieger W; Neppert J; Kerowgan M; Melchert F; Goldmann SF
    Vox Sang; 1995; 68(4):243-7. PubMed ID: 7660645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against Rh D-haemolytic disease of the newborn by a diminished transport of maternal IgG to the fetus.
    Dooren MC; Engelfriet CP
    Vox Sang; 1993; 65(1):59-61. PubMed ID: 8362516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn.
    Hadley AG; Kumpel BM; Leader KA; Poole GD; Fraser ID
    Br J Haematol; 1991 Feb; 77(2):221-8. PubMed ID: 2004024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization.
    Bahr TM; Tweddell SM; Zalla JM; Dizon-Townson D; Ohls RK; Henry E; Ilstrup SJ; Kelley WE; Ling CY; Lindgren PC; O'Brien EA; Christensen RD
    Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38784990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers.
    Thakral B; Agrawal SK; Dhawan HK; Saluja K; Dutta S; Marwaha N
    Hematology; 2007 Oct; 12(5):377-80. PubMed ID: 17852437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newborn.
    Hadley AG
    Vox Sang; 1998; 74 Suppl 2():375-83. PubMed ID: 9704470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal antibodies against fetal blood group antigens A or B: lytic activity of IgG subclasses in monocyte-driven cytotoxicity and correlation with ABO haemolytic disease of the newborn.
    Brouwers HA; Overbeeke MA; Ouwehand WH; Keuning K; van Ertbruggen I; van Leeuwen EF; Stoop JW; Engelfriet CP
    Br J Haematol; 1988 Dec; 70(4):465-9. PubMed ID: 3219297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological and immunological characteristics of maternal anti-Rh(D) antibodies in predicting the severity of haemolytic disease of the newborn.
    Zupańska B; Brojer E; Richards Y; Lenkiewicz B; Seyfried H; Howell P
    Vox Sang; 1989; 56(4):247-53. PubMed ID: 2503936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative and functional asessment of anti-RhD: a comparative study of non-invasive methods in antenatal prediction of Rh hemolytic disease.
    Filbey D; Garner SF; Hadley AG; Shepard SL
    Acta Obstet Gynecol Scand; 1996 Feb; 75(2):102-7. PubMed ID: 8604593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of the severity of haemolytic disease of the newborn. Quantitative IgG anti-D subclass determinations explain the correlation with functional assay results.
    Garner SF; Gorick BD; Lai WY; Brown D; Taverner J; Hughes-Jones NC; Contreras M; Lubenko A
    Vox Sang; 1995; 68(3):169-76. PubMed ID: 7625074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of unexplained mild Rh (D) haemolytic disease in utero.
    Bromilow IM; Downing I; Walkinshaw SA; Welch CR; Duguid JK
    Transfus Med; 1995 Mar; 5(1):31-5. PubMed ID: 7767395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn.
    Hadley AG
    Transpl Immunol; 2002 Aug; 10(2-3):191-8. PubMed ID: 12216949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic disease of newborn due to anti-Jk b in a woman with high risk pregnancy.
    Thakral B; Malhotra S; Saluja K; Kumar P; Marwaha N
    Transfus Apher Sci; 2010 Aug; 43(1):41-3. PubMed ID: 20558106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between maternal HL-A immunization and familial prognosis of haemolytic disease of the newborn due to Rh incompatibility].
    Malinvaud G; Gualde N
    Rev Fr Transfus Immunohematol; 1975 Sep; 18(3):269-80. PubMed ID: 821129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.